ArticleScientific reports2021

A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes.

Chun-Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.